Last viewed:
CLGN
Prices are updated after-hours
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
(0.0% 1d)
(0.2% 1m)
(-25.4% 1y)
(0.0% 2d)
(0.0% 3d)
(1.2% 7d)
(247.72%
volume)
Earnings Calendar: 2024-03-29
Market Cap: $ 60,470,108
http://www.collplant.com
Sec
Filling
|
Patents
| 46 employees
(IL) CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
israel
aesthetic
add to watch list
Paper trade
email alert is off
Press-releases
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Published: 2024-04-04
(Crawled : 20:00)
- biospace.com/
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| -3.13%
| O: -0.18%
H: 0.0%
C: -2.95%
biotechnologies
year
update
financial
results
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - April 4, 2024
Published: 2024-04-04
(Crawled : 12:30)
- biospace.com/
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| -3.13%
| O: -0.18%
H: 0.0%
C: -2.95%
biotechnologies
year
update
financial
results
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Published: 2024-03-26
(Crawled : 12:00)
- prnewswire.com
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| 0.19%
| O: 3.72%
H: 0.0%
C: -3.77%
conference
biotechnologies
year
financial
results
3D Bio-Printing Industry to Surpass a Valuation of US$ 6.82 billion By 2034. Players to Capitalize on the Rising Demand for 3D Bio-printing during the Forecast Period
Published: 2024-01-24
(Crawled : 22:00)
- prnewswire.com
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| -3.31%
| O: -2.57%
H: 0.38%
C: -2.45%
CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
Published: 2024-01-08
(Crawled : 12:30)
- prnewswire.com
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| -14.47%
| O: 1.3%
H: 0.0%
C: -1.28%
california
ceo
aesthetic
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
Published: 2024-01-02
(Crawled : 12:00)
- prnewswire.com
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| -17.68%
| O: -2.82%
H: 6.6%
C: -2.58%
biotechnologies
breast
preclinical
trial
Tissue Engineering Market worth $8.9 billion - Exclusive Report by MarketsandMarkets™
Published: 2023-12-18
(Crawled : 15:30)
- prnewswire.com
SNNUF
|
$12.08
-1.12%
2.5K
|
Health Technology
| -9.0%
| O: 0.87%
H: 0.0%
C: -1.79%
TRUMF
|
$16.488
-17.59%
1.7K
|
Health Technology
| -50.43%
| O: -3.31%
H: 3.79%
C: -0.1%
TRUMY
|
$16.94
0.79%
52K
|
Manufacturing
| -47.81%
| O: 0.4%
H: 0.18%
C: 0.0%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
| -4.36%
| O: -0.46%
H: 0.79%
C: 0.15%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
| 8.99%
| O: -0.68%
H: 0.89%
C: 0.27%
VCEL
|
$46.38
2.2%
2.16%
360K
|
Health Technology
| 23.28%
| O: -0.41%
H: 1.01%
C: -6.49%
MDXG
|
$6.505
2.28%
2.23%
750K
|
Health Technology
| -29.02%
| O: 0.33%
H: 1.56%
C: -2.22%
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| 0.77%
| O: -3.07%
H: 2.17%
C: 0.79%
report
market
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
Published: 2023-11-29
(Crawled : 12:00)
- prnewswire.com
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
| 20.76%
| O: -0.73%
H: 0.78%
C: 0.35%
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| -8.2%
| O: -3.32%
H: 4.15%
C: -3.43%
biotechnologies
financial
results
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Published: 2023-11-09
(Crawled : 15:00)
- biospace.com/
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| -7.07%
| O: -0.18%
H: 0.53%
C: -0.18%
conference
biotechnologies
financial
results
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
Published: 2023-11-01
(Crawled : 11:00)
- prnewswire.com
CLGN
|
$5.28
0.38%
0.38%
13K
|
Health Technology
| -1.68%
| O: 0.19%
H: 23.88%
C: 23.88%
patent
granted
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount